Nobuharu Ohshima

806 citations
56 papers · 566 indexed · h-index 16

Nobuharu Ohshima

54 papers receiving 554 citations

Peers

Nobuharu Ohshima
Comparison fields: 5 of 84
  • Infectious Diseases 164
  • Genetics 93
  • Small Animals 46
  • Immunology and Allergy 33
  • Epidemiology 176
Replace Lenka M. Pereira Arias‐Bouda with:
Lenka M. Pereira Arias‐Bouda Netherlands
Lilia Goudeva Germany
Olga Navolotskaia United States
Bernhard Burian Austria
Jing Bi China
Ivar Følling Norway
Jun Ikari Japan
J C Jensen United States
Makoto Yonemaru Japan
Saif A. Muhsin United States
Nobuharu Ohshima relative to Lenka M. Pereira Arias‐Bouda Netherlands Lenka M. Pereira Arias‐Bouda's profile →
Citations per field
00.5×8.3×
Lenka M. Pereira Arias‐Bouda · 1×
Citations per year

Countries citing papers authored by Nobuharu Ohshima

Since Specialization
Citations

This map shows the geographic impact of Nobuharu Ohshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuharu Ohshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuharu Ohshima more than expected).

Fields of papers citing papers by Nobuharu Ohshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuharu Ohshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuharu Ohshima. The network helps show where Nobuharu Ohshima may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nobuharu Ohshima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nobuharu Ohshima Line = papers co-authored together Nobuharu Ohshima links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20240
3 20231
4 20212
5 202014
6 202015
7 20195
8 201818
9 201721
10 201720
11 201613
12 20154
13 201516
14 201516
15 20142
16 201430
17 201315
18 20122
19 20069
20 200227

About Nobuharu Ohshima

Nobuharu Ohshima is a scholar working on Infectious Diseases, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 566 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (13 papers), Asthma and respiratory diseases (10 papers), Mycobacterium research and diagnosis (8 papers), Infectious Diseases and Tuberculosis (7 papers), Tracheal and airway disorders (6 papers), Respiratory and Cough-Related Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Vascular Anomalies and Treatments (5 papers). The work is most often cited by research in Infectious Diseases (164 citations), Genetics (93 citations) and Small Animals (46 citations). Nobuharu Ohshima has collaborated with scholars based in Japan and United States. Frequent co-authors include Hirotoshi Matsui, Hideaki Nagai, Masahiro Kawashima, Ken Ohta, Junko Suzuki, Keita Takeda, Maho Suzukawa, Kimihiko Masuda, Ryota Sato and Nobuhito Hirawa. Their work appears in journals such as CHEST Journal, Hypertension and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026